Helix Biopharma (CC:HBP) Announces L-DOS47 Scientific Poster to be Presented at American Association for Cancer Research Annual Meeting in Washington, DC
4/8/2013 9:31:31 AM
More...
|
Helix Biopharma (CC:HBP) Initiates Enrollment for Third Cohort and Expansion of Centres in Polish Phase I/II Clinical Study of Its Lung Cancer Drug Candidate L-DOS47
4/5/2013 9:15:24 AM
More...
|
Helix Biopharma (CC:HBP) Announces L-DOS47 Scientific Presentation to be Made at BIT Life Sciences' 5th International Congress of Antibodies
3/19/2013 9:01:02 AM
More...
|
Helix Biopharma (CC:HBP) Announces Q2 Fiscal 2013 Results
3/12/2013 8:44:19 AM
More...
|
Helix Biopharma (CC:HBP) Announces Extension of 2009 Warrant Expiry Date
3/8/2013 8:40:42 AM
More...
|
Helix Biopharma (CC:HBP) Announces Director Resignation
2/25/2013 9:40:16 AM
More...
|
Helix Biopharma (CC:HBP) Announces Extension of 2009 Warrant Expiry Date
2/22/2013 9:32:38 AM
More...
|
Helix Biopharma (CC:HBP) Announces Appointment of Director
2/22/2013 9:32:01 AM
More...
|
Helix Biopharma (CC:HBP) Announces Director Resignation
2/11/2013 9:35:27 AM
More...
|
Helix Biopharma (CC:HBP) Announces Completion of the Sale of Its Rivex Pharma Division to Pharmascience Inc.
1/28/2013 8:42:56 AM
More...
|
|